Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spleen Transplant as an Immunomodulatory Strategy in Solid Organ Transplantation

NCT04827186 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT04827186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04827186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spleen Transplant as an Immunomodulatory Strategy in Solid Organ Transplantation
Lead sponsor
University of Illinois at Chicago
Phase
Not applicable
Overall status
Withdrawn
Start date
March 26, 2021
Completion date
April 1, 2026
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant rejection, kidney/pancreas transplant rejection, positive cdc cross-match (b cell positive), positive fcxm (t or b cell positive)